25 XP   0   0   10

Quantum Genomics SA
Buy, Hold or Sell?

Let's analyse Quantum Genomics SA together

PenkeI guess you are interested in Quantum Genomics SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Quantum Genomics SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Quantum Genomics SA

I send you an email if I find something interesting about Quantum Genomics SA.

Quick analysis of Quantum Genomics SA (30 sec.)










What can you expect buying and holding a share of Quantum Genomics SA? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.05
Expected worth in 1 year
€-0.35
How sure are you?
42.5%

+ What do you gain per year?

Total Gains per Share
€-0.39
Return On Investment
-305.4%

For what price can you sell your share?

Current Price per Share
€0.13
Expected price per share
€0.1002 - €0.155
How sure are you?
50%

1. Valuation of Quantum Genomics SA (5 min.)




Live pricePrice per Share (EOD)

€0.13

Intrinsic Value Per Share

€-11.32 - €-6.71

Total Value Per Share

€-11.28 - €-6.66

2. Growth of Quantum Genomics SA (5 min.)




Is Quantum Genomics SA growing?

Current yearPrevious yearGrowGrow %
How rich?$1.7m$15.1m-$8.7m-134.7%

How much money is Quantum Genomics SA making?

Current yearPrevious yearGrowGrow %
Making money-$6m-$9.2m$3.2m54.6%
Net Profit Margin-5,741.6%-414.5%--

How much money comes from the company's main activities?

3. Financial Health of Quantum Genomics SA (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#773 / 1010

Most Revenue
#413 / 1010

Most Profit
#755 / 1010

Most Efficient
#801 / 1010

What can you expect buying and holding a share of Quantum Genomics SA? (5 min.)

Welcome investor! Quantum Genomics SA's management wants to use your money to grow the business. In return you get a share of Quantum Genomics SA.

What can you expect buying and holding a share of Quantum Genomics SA?

First you should know what it really means to hold a share of Quantum Genomics SA. And how you can make/lose money.

Speculation

The Price per Share of Quantum Genomics SA is €0.1292. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Quantum Genomics SA.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Quantum Genomics SA, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.05. Based on the TTM, the Book Value Change Per Share is €-0.10 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Quantum Genomics SA.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.03-23.6%-0.11-83.1%-0.18-137.8%-0.11-85.9%-0.08-59.9%
Usd Book Value Change Per Share-0.05-35.7%-0.11-81.7%-0.05-40.2%0.00-2.0%0.001.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-35.7%-0.11-81.7%-0.05-40.2%0.00-2.0%0.001.5%
Usd Price Per Share0.18-0.85-3.85-3.45-4.29-
Price to Earnings Ratio-1.46--1.62--5.47--8.87--23.01-
Price-to-Total Gains Ratio-3.88--2.11--0.10-31.93-2,313,474.26-
Price to Book Ratio3.58-3.10-9.80-8.46--44.18-
Price-to-Total Gains Ratio-3.88--2.11--0.10-31.93-2,313,474.26-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.13823108
Number of shares7234
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.110.00
Usd Total Gains Per Share-0.110.00
Gains per Quarter (7234 shares)-763.52-18.54
Gains per Year (7234 shares)-3,054.09-74.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3054-30640-74-84
20-6108-61180-148-158
30-9162-91720-223-232
40-12216-122260-297-306
50-15270-152800-371-380
60-18325-183340-445-454
70-21379-213880-519-528
80-24433-244420-593-602
90-27487-274960-668-676
100-30541-305500-742-750

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%0.047.00.00.0%
Book Value Change Per Share0.02.02.00.0%2.04.06.016.7%6.06.08.030.0%17.015.08.042.5%17.017.013.036.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.047.00.0%
Total Gains per Share0.02.02.00.0%2.04.06.016.7%6.06.08.030.0%17.015.08.042.5%17.017.013.036.2%

Fundamentals of Quantum Genomics SA

About Quantum Genomics SA

Quantum Genomics Société Anonyme, a biopharmaceutical company, engages in the development of drugs to treat cardiovascular diseases. The company develops its drugs based on brain inhibition mechanism of Aminopeptidase A: BAPAI, a triple-action therapeutic platform primarily to treat high blood pressure and heart failure. It is developing firibastat, a treatment for high blood pressure, and in combination with others anti-hypertensive drugs. The company also is involved in the development of drugs for the treatment of high blood pressure as monotherapy and the prevention, as well as treatment of heart failure. Quantum Genomics Société Anonyme was incorporated in 2005 and is based in Paris, France.

Fundamental data was last updated by Penke on 2024-04-09 12:54:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Quantum Genomics SA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Quantum Genomics SA earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Quantum Genomics SA to the Biotechnology industry mean.
  • A Net Profit Margin of -19,737.6% means that €-197.38 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Quantum Genomics SA:

  • The MRQ is -19,737.6%. The company is making a huge loss. -2
  • The TTM is -5,741.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-19,737.6%TTM-5,741.6%-13,996.0%
TTM-5,741.6%YOY-414.5%-5,327.0%
TTM-5,741.6%5Y-1,723.6%-4,018.0%
5Y-1,723.6%10Y-34,885,618.3%+34,883,894.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-19,737.6%-207.2%-19,530.4%
TTM-5,741.6%-216.8%-5,524.8%
YOY-414.5%-282.3%-132.2%
5Y-1,723.6%-436.8%-1,286.8%
10Y-34,885,618.3%-597.3%-34,885,021.0%
1.1.2. Return on Assets

Shows how efficient Quantum Genomics SA is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Quantum Genomics SA to the Biotechnology industry mean.
  • -34.5% Return on Assets means that Quantum Genomics SA generated €-0.34 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Quantum Genomics SA:

  • The MRQ is -34.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -29.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-34.5%TTM-29.4%-5.1%
TTM-29.4%YOY-35.5%+6.2%
TTM-29.4%5Y-22.8%-6.6%
5Y-22.8%10Y-20.2%-2.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-34.5%-13.3%-21.2%
TTM-29.4%-12.8%-16.6%
YOY-35.5%-11.6%-23.9%
5Y-22.8%-13.8%-9.0%
10Y-20.2%-15.6%-4.6%
1.1.3. Return on Equity

Shows how efficient Quantum Genomics SA is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Quantum Genomics SA to the Biotechnology industry mean.
  • -122.3% Return on Equity means Quantum Genomics SA generated €-1.22 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Quantum Genomics SA:

  • The MRQ is -122.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -138.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-122.3%TTM-138.0%+15.7%
TTM-138.0%YOY-70.2%-67.8%
TTM-138.0%5Y-56.0%-82.0%
5Y-56.0%10Y-47.0%-9.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-122.3%-16.9%-105.4%
TTM-138.0%-16.1%-121.9%
YOY-70.2%-14.9%-55.3%
5Y-56.0%-19.3%-36.7%
10Y-47.0%-20.1%-26.9%

1.2. Operating Efficiency of Quantum Genomics SA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Quantum Genomics SA is operating .

  • Measures how much profit Quantum Genomics SA makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Quantum Genomics SA to the Biotechnology industry mean.
  • An Operating Margin of -19,886.1% means the company generated €-198.86  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Quantum Genomics SA:

  • The MRQ is -19,886.1%. The company is operating very inefficient. -2
  • The TTM is -6,111.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-19,886.1%TTM-6,111.2%-13,774.9%
TTM-6,111.2%YOY-430.5%-5,680.8%
TTM-6,111.2%5Y-1,689.0%-4,422.3%
5Y-1,689.0%10Y-38,913,244.5%+38,911,555.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-19,886.1%-298.0%-19,588.1%
TTM-6,111.2%-238.5%-5,872.7%
YOY-430.5%-288.4%-142.1%
5Y-1,689.0%-486.2%-1,202.8%
10Y-38,913,244.5%-628.4%-38,912,616.1%
1.2.2. Operating Ratio

Measures how efficient Quantum Genomics SA is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 199.86 means that the operating costs are €199.86 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Quantum Genomics SA:

  • The MRQ is 199.862. The company is inefficient in keeping operating costs low. -1
  • The TTM is 61.714. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ199.862TTM61.714+138.148
TTM61.714YOY4.796+56.917
TTM61.7145Y17.844+43.870
5Y17.84410Y219,055.426-219,037.582
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ199.8623.235+196.627
TTM61.7143.310+58.404
YOY4.7963.838+0.958
5Y17.8445.679+12.165
10Y219,055.4267.823+219,047.603

1.3. Liquidity of Quantum Genomics SA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Quantum Genomics SA is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.61 means the company has €4.61 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Quantum Genomics SA:

  • The MRQ is 4.611. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.970. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ4.611TTM2.970+1.640
TTM2.970YOY2.876+0.094
TTM2.9705Y3.332-0.361
5Y3.33210Y3.042+0.289
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6113.863+0.748
TTM2.9704.169-1.199
YOY2.8765.337-2.461
5Y3.3326.122-2.790
10Y3.0426.434-3.392
1.3.2. Quick Ratio

Measures if Quantum Genomics SA is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Quantum Genomics SA to the Biotechnology industry mean.
  • A Quick Ratio of 4.58 means the company can pay off €4.58 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Quantum Genomics SA:

  • The MRQ is 4.576. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.056. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.576TTM2.056+2.520
TTM2.056YOY1.367+0.689
TTM2.0565Y1.942+0.113
5Y1.94210Y1.954-0.012
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5763.504+1.072
TTM2.0563.991-1.935
YOY1.3675.371-4.004
5Y1.9426.088-4.146
10Y1.9546.395-4.441

1.4. Solvency of Quantum Genomics SA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Quantum Genomics SA assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Quantum Genomics SA to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.72 means that Quantum Genomics SA assets are financed with 71.8% credit (debt) and the remaining percentage (100% - 71.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Quantum Genomics SA:

  • The MRQ is 0.718. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.712. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.718TTM0.712+0.006
TTM0.712YOY0.460+0.251
TTM0.7125Y0.414+0.297
5Y0.41410Y0.504-0.089
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7180.339+0.379
TTM0.7120.337+0.375
YOY0.4600.271+0.189
5Y0.4140.368+0.046
10Y0.5040.388+0.116
1.4.2. Debt to Equity Ratio

Measures if Quantum Genomics SA is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Quantum Genomics SA to the Biotechnology industry mean.
  • A Debt to Equity ratio of 254.6% means that company has €2.55 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Quantum Genomics SA:

  • The MRQ is 2.546. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.606. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.546TTM3.606-1.061
TTM3.606YOY0.907+2.700
TTM3.6065Y1.168+2.438
5Y1.16810Y1.242-0.074
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5460.392+2.154
TTM3.6060.403+3.203
YOY0.9070.335+0.572
5Y1.1680.427+0.741
10Y1.2420.461+0.781

2. Market Valuation of Quantum Genomics SA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Quantum Genomics SA generates.

  • Above 15 is considered overpriced but always compare Quantum Genomics SA to the Biotechnology industry mean.
  • A PE ratio of -1.46 means the investor is paying €-1.46 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Quantum Genomics SA:

  • The EOD is -1.131. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.464. Based on the earnings, the company is expensive. -2
  • The TTM is -1.615. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.131MRQ-1.464+0.333
MRQ-1.464TTM-1.615+0.151
TTM-1.615YOY-5.466+3.851
TTM-1.6155Y-8.874+7.259
5Y-8.87410Y-23.011+14.137
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.131-2.300+1.169
MRQ-1.464-2.656+1.192
TTM-1.615-2.718+1.103
YOY-5.466-4.145-1.321
5Y-8.874-6.258-2.616
10Y-23.011-6.315-16.696
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Quantum Genomics SA:

  • The EOD is -0.147. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.190. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.472. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.147MRQ-0.190+0.043
MRQ-0.190TTM-1.472+1.282
TTM-1.472YOY-4.371+2.899
TTM-1.4725Y-8.161+6.689
5Y-8.16110Y-22.476+14.315
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.147-2.974+2.827
MRQ-0.190-3.306+3.116
TTM-1.472-3.508+2.036
YOY-4.371-5.613+1.242
5Y-8.161-8.378+0.217
10Y-22.476-8.873-13.603
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Quantum Genomics SA is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.58 means the investor is paying €3.58 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Quantum Genomics SA:

  • The EOD is 2.767. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.581. Based on the equity, the company is fair priced.
  • The TTM is 3.097. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.767MRQ3.581-0.814
MRQ3.581TTM3.097+0.484
TTM3.097YOY9.803-6.705
TTM3.0975Y8.462-5.365
5Y8.46210Y-44.175+52.637
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.7671.914+0.853
MRQ3.5812.116+1.465
TTM3.0972.097+1.000
YOY9.8032.881+6.922
5Y8.4623.550+4.912
10Y-44.1753.936-48.111
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Quantum Genomics SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.043-0.099+129%-0.048+12%-0.002-94%0.002-2460%
Book Value Per Share--0.0470.167-72%0.408-89%0.377-88%0.275-83%
Current Ratio--4.6112.970+55%2.876+60%3.332+38%3.042+52%
Debt To Asset Ratio--0.7180.712+1%0.460+56%0.414+73%0.504+42%
Debt To Equity Ratio--2.5463.606-29%0.907+181%1.168+118%1.242+105%
Dividend Per Share----0%-0%-0%-0%
Eps---0.029-0.100+252%-0.166+483%-0.104+263%-0.072+153%
Free Cash Flow Per Share---0.220-0.168-23%-0.242+10%-0.142-35%-0.091-59%
Free Cash Flow To Equity Per Share---0.220-0.166-24%-0.058-74%-0.031-86%0.031-808%
Gross Profit Margin--1.0001.0000%1.0000%1.070-7%1.056-5%
Intrinsic Value_10Y_max---6.711--------
Intrinsic Value_10Y_min---11.324--------
Intrinsic Value_1Y_max---0.410--------
Intrinsic Value_1Y_min---0.749--------
Intrinsic Value_3Y_max---1.431--------
Intrinsic Value_3Y_min---2.598--------
Intrinsic Value_5Y_max---2.694--------
Intrinsic Value_5Y_min---4.813--------
Market Cap4491470.040-29%5812490.64027823620.245-79%125114556.300-95%112065057.184-95%139510601.402-96%
Net Profit Margin---197.376-57.416-71%-4.145-98%-17.236-91%-348856.183+176647%
Operating Margin---198.861-61.112-69%-4.305-98%-16.890-92%-389132.445+195580%
Operating Ratio--199.86261.714+224%4.796+4067%17.844+1020%219055.426-100%
Pb Ratio2.767-29%3.5813.097+16%9.803-63%8.462-58%-44.175+1334%
Pe Ratio-1.131+23%-1.464-1.615+10%-5.466+273%-8.874+506%-23.011+1472%
Price Per Share0.129-29%0.1670.792-79%3.599-95%3.222-95%4.012-96%
Price To Free Cash Flow Ratio-0.147+23%-0.190-1.472+674%-4.371+2198%-8.161+4190%-22.476+11715%
Price To Total Gains Ratio-2.995+23%-3.876-2.106-46%-0.099-97%31.925-112%2313474.263-100%
Quick Ratio--4.5762.056+123%1.367+235%1.942+136%1.954+134%
Return On Assets---0.345-0.294-15%-0.355+3%-0.228-34%-0.202-41%
Return On Equity---1.223-1.380+13%-0.702-43%-0.560-54%-0.470-62%
Total Gains Per Share---0.043-0.099+129%-0.048+12%-0.002-94%0.002-2460%
Usd Book Value--1736621.0246467380.735-73%15181825.900-89%14073172.464-88%10269309.260-83%
Usd Book Value Change Per Share---0.046-0.106+129%-0.052+12%-0.003-94%0.002-2460%
Usd Book Value Per Share--0.0500.179-72%0.437-89%0.403-88%0.295-83%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.031-0.107+252%-0.178+483%-0.111+263%-0.077+153%
Usd Free Cash Flow---8172897.626-6721661.729-18%-8986357.575+10%-5369227.672-34%-3436800.344-58%
Usd Free Cash Flow Per Share---0.235-0.180-23%-0.258+10%-0.152-35%-0.098-59%
Usd Free Cash Flow To Equity Per Share---0.235-0.178-24%-0.062-74%-0.033-86%0.033-808%
Usd Market Cap4805423.796-29%6218783.73629768491.300-79%133860063.785-95%119898404.681-95%149262392.440-96%
Usd Price Per Share0.138-29%0.1790.847-79%3.851-95%3.447-95%4.293-96%
Usd Profit---2124392.370-6004987.074+183%-9281174.939+337%-5267518.164+148%-3442712.511+62%
Usd Revenue--10763.194110233.134-90%1158747.706-99%338844.124-97%172117.789-94%
Usd Total Gains Per Share---0.046-0.106+129%-0.052+12%-0.003-94%0.002-2460%
 EOD+3 -5MRQTTM+12 -21YOY+15 -185Y+7 -2710Y+9 -25

3.2. Fundamental Score

Let's check the fundamental score of Quantum Genomics SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.131
Price to Book Ratio (EOD)Between0-12.767
Net Profit Margin (MRQ)Greater than0-197.376
Operating Margin (MRQ)Greater than0-198.861
Quick Ratio (MRQ)Greater than14.576
Current Ratio (MRQ)Greater than14.611
Debt to Asset Ratio (MRQ)Less than10.718
Debt to Equity Ratio (MRQ)Less than12.546
Return on Equity (MRQ)Greater than0.15-1.223
Return on Assets (MRQ)Greater than0.05-0.345
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Quantum Genomics SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.557
Ma 20Greater thanMa 500.112
Ma 50Greater thanMa 1000.108
Ma 100Greater thanMa 2000.106
OpenGreater thanClose0.127
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets3,747
Total Liabilities3,310
Total Stockholder Equity437
 As reported
Total Liabilities 3,310
Total Stockholder Equity+ 437
Total Assets = 3,747

Assets

Total Assets3,747
Total Current Assets3,687
Long-term Assets60
Total Current Assets
Cash And Cash Equivalents 3,547
Net Receivables 119
Other Current Assets 21
Total Current Assets  (as reported)3,687
Total Current Assets  (calculated)3,687
+/-0
Long-term Assets
Property Plant Equipment 8
Other Assets 0
Long-term Assets  (as reported)60
Long-term Assets  (calculated)8
+/- 52

Liabilities & Shareholders' Equity

Total Current Liabilities1,350
Long-term Liabilities1,960
Total Stockholder Equity437
Total Current Liabilities
Short-term Debt 757
Accounts payable 272
Other Current Liabilities 321
Total Current Liabilities  (as reported)1,350
Total Current Liabilities  (calculated)1,350
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)1,960
Long-term Liabilities  (calculated)0
+/- 1,960
Total Stockholder Equity
Common Stock13,936
Retained Earnings -28,106
Other Stockholders Equity 14,607
Total Stockholder Equity (as reported)437
Total Stockholder Equity (calculated)437
+/-0
Other
Cash and Short Term Investments 3,547
Common Stock Shares Outstanding 34,486
Liabilities and Stockholders Equity 3,747
Net Debt -831
Short Long Term Debt Total 2,717



Balance Sheet

All numbers in thousands.

 Trend2023-12-312023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312010-12-312009-12-31
> Total Assets 
846
846
850
0
0
0
1,057
0
0
1,693
1,693
2,743
2,743
4,753
4,753
12,894
12,894
10,540
10,540
15,845
15,845
14,511
14,511
10,697
10,697
13,917
13,917
9,674
8,934
18,480
18,480
16,581
16,581
0
15,106
0
18,547
0
34,952
0
32,419
0
21,242
0
27,059
0
23,658
0
5,755
3,747
3,7475,755023,658027,059021,242032,419034,952018,547015,106016,58116,58118,48018,4808,9349,67413,91713,91710,69710,69714,51114,51115,84515,84510,54010,54012,89412,8944,7534,7532,7432,7431,6931,693001,057000850846846
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
1,146
0
2,095
0
4,129
0
11,175
0
10,020
0
15,351
13,808
13,808
10,090
10,090
13,476
13,476
9,237
8,496
17,855
17,855
15,641
15,641
14,222
14,222
17,659
17,659
33,488
33,498
31,123
31,123
20,232
20,232
26,229
26,229
23,395
23,395
5,640
5,640
3,687
3,6875,6405,64023,39523,39526,22926,22920,23220,23231,12331,12333,49833,48817,65917,65914,22214,22215,64115,64117,85517,8558,4969,23713,47613,47610,09010,09013,80813,80815,351010,020011,17504,12902,09501,1460000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
334
0
1,078
0
3,318
0
1,050
0
4,552
0
4,225
2,198
2,198
2,319
2,319
6,088
6,088
5,963
5,963
14,789
14,789
6,625
6,625
0
6,164
0
8,191
0
22,148
0
19,867
0
13,552
0
19,447
0
10,401
0
2,758
3,547
3,5472,758010,401019,447013,552019,867022,14808,19106,16406,6256,62514,78914,7895,9635,9636,0886,0882,3192,3192,1982,1984,22504,55201,05003,31801,07803340000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,100
0
4,100
0
9,000
9,000
9,000
5,000
5,000
5,002
5,002
8
8
8
8
5,001
5,001
0
5,000
0
5,002
0
5,005
0
5,007
0
257
0
136
0
32
0
0
0
000320136025705,00705,00505,00205,00005,0015,00188885,0025,0025,0005,0009,0009,0009,00004,10009,1000000000000000000
       Net Receivables 
326
226
385
0
0
0
657
0
0
753
753
932
932
645
645
875
875
1,071
1,071
1,573
1,573
1,411
1,411
2,001
2,001
1,614
1,614
2,387
2,387
2,021
2,021
2,782
2,782
2,005
2,005
1,612
1,612
3,837
3,837
2,768
2,768
3,881
696
2,980
2,980
12,900
1
2,839
2,839
119
1192,8392,839112,9002,9802,9806963,8812,7682,7683,8373,8371,6121,6122,0052,0052,7822,7822,0212,0212,3872,3871,6141,6142,0012,0011,4111,4111,5731,5731,0711,07187587564564593293275375300657000385226326
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14
14
125
125
1,011
1,011
449
449
189
189
139
139
422
422
422
422
333
333
1,070
1,070
1,747
1,747
0
0
0
-696
0
0
0
0
0
0
0
0000000-6960001,7471,7471,0701,0703333334224224224221391391891894494491,0111,011125125141400000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
547
0
648
0
624
0
1,719
0
520
0
494
0
703
0
607
0
442
0
438
0
626
0
940
0
884
0
888
0
1,454
0
1,297
0
979
0
830
0
230
0
115
60
6011502300830097901,29701,454088808840940062604380442060707030494052001,7190624064805470000000000
       Property Plant Equipment 
26
21
30
0
0
0
23
0
0
17
17
20
20
32
32
54
54
54
54
46
46
60
60
431
431
52
52
59
59
24
24
34
34
27
27
27
27
27
27
34
34
442
442
386
386
23
23
19
19
8
8191923233863864424423434272727272727343424245959525243143160604646545454543232202017170023000302126
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40
0
40
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000400400000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
476
476
0
0
258
258
254
254
564
564
608
608
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000060860856456425425425825800476476000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
66
0
0
313
313
69
432
104
429
113
1,234
108
108
104
104
142
142
136
136
91
91
87
87
0
0
260
260
0
360
0
360
0
760
0
666
0
537
0
411
0
0
0
0
0
0000041105370666076003600360026026000878791911361361421421041041081081,234113429104432693133130066000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
216
0
196
0
162
0
9,100
0
4,100
0
9,000
0
9,001
0
5,002
0
5,004
0
8
0
8
0
5,001
0
5,000
0
5,003
0
5,005
0
0
0
-979
0
-797
0
-230
0
1
0
010-2300-7970-9790005,00505,00305,00005,001080805,00405,00209,00109,00004,10009,1000162019602160000000000
> Total Liabilities 
835
1,545
1,261
0
0
0
1,975
0
0
3,321
3,321
1,988
1,988
4,882
4,882
1,881
1,881
2,518
2,518
2,817
2,817
3,987
3,987
4,012
4,012
5,046
5,046
6,385
5,645
6,613
5,583
5,482
4,512
0
4,243
0
7,241
0
7,097
0
10,334
0
11,575
0
11,718
0
20,050
0
4,132
3,310
3,3104,132020,050011,718011,575010,33407,09707,24104,24304,5125,4825,5836,6135,6456,3855,0465,0464,0124,0123,9873,9872,8172,8172,5182,5181,8811,8814,8824,8821,9881,9883,3213,321001,9750001,2611,545835
   > Total Current Liabilities 
351
805
521
0
0
0
1,333
0
0
2,736
2,624
1,455
1,392
4,155
4,155
1,053
1,053
1,791
1,791
2,029
2,029
2,716
2,716
2,664
2,664
3,778
3,778
5,116
5,116
5,316
5,316
4,509
4,509
4,240
3,946
4,891
6,988
7,085
6,637
10,333
8,391
7,867
7,867
8,247
8,247
17,590
17,590
1,223
1,223
1,350
1,3501,2231,22317,59017,5908,2478,2477,8677,8678,39110,3336,6377,0856,9884,8913,9464,2404,5094,5095,3165,3165,1165,1163,7783,7782,6642,6642,7162,7162,0292,0291,7911,7911,0531,0534,1554,1551,3921,4552,6242,736001,333000521805351
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
1,053
0
187
0
3,308
0
1
0
1
0
1
1
1
1
1
1
1
1
1
0
2
0
1
0
1
0
2,352
0
2
0
1,504
0
3
0
352
0
2
0
0
757
75700203520301,5040202,3520101020111111111010103,308018701,0530000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
0
0
0
0
1
0
1
0
2,352
0
2
0
1,504
0
0
0
222
0
0
0
0
0
000002220001,5040202,352010100001111111000000000000000000000
       Accounts payable 
277
341
382
0
0
0
849
0
0
1,223
1,223
678
678
569
569
599
599
1,400
1,400
1,571
1,571
2,212
2,212
2,201
2,201
3,313
3,313
4,548
4,548
4,732
4,732
3,606
3,606
3,367
3,367
4,134
4,134
6,036
6,036
6,426
6,426
6,746
6,746
5,696
5,696
16,008
16,008
546
546
272
27254654616,00816,0085,6965,6966,7466,7466,4266,4266,0366,0364,1344,1343,3673,3673,6063,6064,7324,7324,5484,5483,3133,3132,2012,2012,2122,2121,5711,5711,4001,4005995995695696786781,2231,22300849000382341277
       Other Current Liabilities 
74
343
139
0
0
0
65
0
0
490
490
595
595
279
279
453
453
390
390
458
458
502
502
462
462
464
464
60
60
12
12
53
902
6
578
61
476
42
599
66
461
185
1,121
1,653
1,075
7
1,581
678
678
321
3216786781,58171,0751,6531,12118546166599424766157869025312126060464464462462502502458458390390453453279279595595490490006500013934374
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
697
0
596
0
727
0
827
0
727
0
788
0
1,271
0
1,347
0
1,267
0
529
0
267
0
3
0
297
0
253
0
460
0
1,943
0
2,882
0
3,471
0
2,416
0
2,909
1,960
1,9602,90902,41603,47102,88201,943046002530297030267052901,26701,34701,2710788072708270727059606970000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,502
0
284
0
3,032
0
616
0
2,909
0
02,909061603,032028401,5020000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
-1,053
0
-187
0
-3,308
0
-1
0
-1
0
-1
-1
-1
-1
-1
-1
-1
-1
-1
0
-2
0
-1
0
-1
0
-2,352
0
-2
0
-1,504
0
-3
0
11
0
-2
0
0
-757
-75700-20110-30-1,5040-20-2,3520-10-10-20-1-1-1-1-1-1-1-1-10-10-10-3,3080-1870-1,0530000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
3
0
0
0
1
0
23
0
48
0
41
0
10
0
0
0
000100410480230100030300000000000000000000000000000000
> Total Stockholder Equity
11
0
0
0
0
0
0
0
0
0
0
756
756
0
0
11,013
11,013
8,022
8,022
13,029
13,029
10,524
10,524
6,686
6,686
8,872
8,872
3,289
3,289
11,868
11,868
11,099
12,069
0
10,864
0
11,305
0
27,855
0
22,085
0
9,667
0
15,341
0
3,608
0
1,623
437
4371,62303,608015,34109,667022,085027,855011,305010,864012,06911,09911,86811,8683,2893,2898,8728,8726,6866,68610,52410,52413,02913,0298,0228,02211,01311,01300756756000000000011
   Retained Earnings -28,106-26,920-26,920-24,934-24,934-13,195-8,736-16,556-16,458-6,180-5,958-11,537-11,319-14,159-13,982-9,078-8,901-4,129-4,127-11,990-38,390-32,704-32,606-26,496-26,313-21,152-20,943-17,114-16,815-14,6250-11,8730-9,9500-8,1660-7,2370-5,9590000000000
   Accumulated Other Comprehensive Income 00000-13,19500000-650-68000-710-80000-660-590-500-580-480-400-480-440-410000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,482
0
11,849
0
16,249
0
27,774
0
17,021
0
16,913
0
14,578
0
14,605
0
14,607
0
014,607014,605014,578016,913017,021027,774016,249011,84908,48200000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue10
Cost of Revenue-3,026
Gross Profit-3,016-3,016
 
Operating Income (+$)
Gross Profit-3,016
Operating Expense-137
Operating Income-3,153-3,153
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense1370
 
Net Interest Income (+$)
Interest Income-
Interest Expense-21
Other Finance Cost-21
Net Interest Income-
 
Pretax Income (+$)
Operating Income-3,153
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-3,205-3,101
EBIT - interestExpense = -3,175
-3,205
-3,150
Interest Expense21
Earnings Before Interest and Taxes (EBIT)-3,153-3,184
Earnings Before Interest and Taxes (EBITDA)-3,145
 
After tax Income (+$)
Income Before Tax-3,205
Tax Provision--
Net Income From Continuing Ops--3,205
Net Income-3,171
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses3,163
Total Other Income/Expenses Net-520
 

Technical Analysis of Quantum Genomics SA
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Quantum Genomics SA. The general trend of Quantum Genomics SA is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Quantum Genomics SA's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Quantum Genomics SA.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.13 < 0.1326 < 0.155.

The bearish price targets are: 0.125 > 0.122 > 0.1002.

Tweet this
Quantum Genomics SA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Quantum Genomics SA. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Quantum Genomics SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Quantum Genomics SA. The current macd is 0.00537446.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Quantum Genomics SA price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Quantum Genomics SA. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Quantum Genomics SA price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Quantum Genomics SA Daily Moving Average Convergence/Divergence (MACD) ChartQuantum Genomics SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Quantum Genomics SA. The current adx is 70.31.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Quantum Genomics SA shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Quantum Genomics SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Quantum Genomics SA. The current sar is 0.10169688.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Quantum Genomics SA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Quantum Genomics SA. The current rsi is 66.56. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Quantum Genomics SA Daily Relative Strength Index (RSI) ChartQuantum Genomics SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Quantum Genomics SA. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Quantum Genomics SA price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Quantum Genomics SA Daily Stochastic Oscillator ChartQuantum Genomics SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Quantum Genomics SA. The current cci is 171.02.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Quantum Genomics SA Daily Commodity Channel Index (CCI) ChartQuantum Genomics SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Quantum Genomics SA. The current cmo is 37.81.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Quantum Genomics SA Daily Chande Momentum Oscillator (CMO) ChartQuantum Genomics SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Quantum Genomics SA. The current willr is -23.40425532.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Quantum Genomics SA is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Quantum Genomics SA Daily Williams %R ChartQuantum Genomics SA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Quantum Genomics SA.

Quantum Genomics SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Quantum Genomics SA. The current atr is 0.00885702.

Quantum Genomics SA Daily Average True Range (ATR) ChartQuantum Genomics SA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Quantum Genomics SA. The current obv is -14,105,406.

Quantum Genomics SA Daily On-Balance Volume (OBV) ChartQuantum Genomics SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Quantum Genomics SA. The current mfi is 89.81.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Quantum Genomics SA Daily Money Flow Index (MFI) ChartQuantum Genomics SA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Quantum Genomics SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Quantum Genomics SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Quantum Genomics SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.557
Ma 20Greater thanMa 500.112
Ma 50Greater thanMa 1000.108
Ma 100Greater thanMa 2000.106
OpenGreater thanClose0.127
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Quantum Genomics SA with someone you think should read this too:
  • Are you bullish or bearish on Quantum Genomics SA? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Quantum Genomics SA? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Quantum Genomics SA

I send you an email if I find something interesting about Quantum Genomics SA.


Comments

How you think about this?

Leave a comment

Stay informed about Quantum Genomics SA.

Receive notifications about Quantum Genomics SA in your mailbox!